Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma

Zimmer, Lisa; Apuri, Susmitha; Eroglu, Zeynep; Kottschade, Lisa A.; Forschner, Andrea; Gutzmer, Ralf; Schlaak, Max; Heinzerling, Lucie; Krackhardt, Angela M.; Loquai, Carmen; Markovic, Svetomir N.; Joseph, Richard W.; Markey, Kelly; Utikal, Jochen S.; Weishaupt, Carsten; Goldinger, Simone M.; Sondak, Vernon K.; Zager, Jonathan S.; Schadendorf, Dirk; Khushalani, Nikhil I.

dc.contributor.author	Forschner, Andrea Lydia
dc.date.accessioned	2017-12-20T12:22:42Z
dc.date.available	2017-12-20T12:22:42Z
dc.date.issued	2017
dc.identifier.issn	1879-0852
dc.identifier.uri	http://hdl.handle.net/10900/79475
dc.language.iso	en	de_DE
dc.publisher	Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ejca.2017.01.009	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20170815222223_01206
utue.publikation.seiten	47-55	de_DE
utue.personen.roh	Zimmer, Lisa
utue.personen.roh	Apuri, Susmitha
utue.personen.roh	Eroglu, Zeynep
utue.personen.roh	Kottschade, Lisa A.
utue.personen.roh	Forschner, Andrea
utue.personen.roh	Gutzmer, Ralf
utue.personen.roh	Schlaak, Max
utue.personen.roh	Heinzerling, Lucie
utue.personen.roh	Krackhardt, Angela M.
utue.personen.roh	Loquai, Carmen
utue.personen.roh	Markovic, Svetomir N.
utue.personen.roh	Joseph, Richard W.
utue.personen.roh	Markey, Kelly
utue.personen.roh	Utikal, Jochen S.
utue.personen.roh	Weishaupt, Carsten
utue.personen.roh	Goldinger, Simone M.
utue.personen.roh	Sondak, Vernon K.
utue.personen.roh	Zager, Jonathan S.
utue.personen.roh	Schadendorf, Dirk
utue.personen.roh	Khushalani, Nikhil I.
dcterms.isPartOf.ZSTitelID	European Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Volume	75	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE